Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial

DOI record: { "DOI": "10.1007/s10787-022-01001-2", "ISSN": [ "0925-4692", "1568-5608" ], "URL": "http://dx.doi.org/10.1007/s10787-022-01001-2", "alternative-id": [ "1001" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "19 April 2022" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "21 April 2022" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "20 June 2022" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Conflict of interest", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "The authors have no relevant financial or non-financial interests to disclose." }, { "label": "Free to read", "name": "free", "value": "This content has been made available to all." } ], "author": [ { "affiliation": [], "family": "Moslemi", "given": "Mohammadreza", "sequence": "first" }, { "affiliation": [], "family": "Hejazian", "given": "Seyyedeh Mina", "sequence": "additional" }, { "affiliation": [], "family": "Shaddelan", "given": "Molod", "sequence": "additional" }, { "affiliation": [], "family": "Javanali", "given": "Fatemeh", "sequence": "additional" }, { "affiliation": [], "family": "Mirghaffari", "given": "Alireza", "sequence": "additional" }, { "affiliation": [], "family": "Sadeghi", "given": "Armin", "sequence": "additional" }, { "affiliation": [], "family": "Valizadeh", "given": "Hamed", "sequence": "additional" }, { "affiliation": [], "family": "Sharifi", "given": "Akbar", "sequence": "additional" }, { "affiliation": [], "family": "Haramshahi", "given": "Morteza", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-6851-5460", "affiliation": [], "authenticated-orcid": false, "family": "Ardalan", "given": "Mohammadreza", "sequence": "additional" }, { "affiliation": [], "family": "Zununi Vahed", "given": "Sepideh", "sequence": "additional" } ], "container-title": "Inflammopharmacology", "container-title-short": "Inflammopharmacol", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2022, 6, 20 ] ], "date-time": "2022-06-20T10:04:07Z", "timestamp": 1655719447000 }, "deposited": { "date-parts": [ [ 2022, 7, 18 ] ], "date-time": "2022-07-18T17:12:25Z", "timestamp": 1658164345000 }, "funder": [ { "DOI": "10.13039/501100004366", "award": [ "65395" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100004366", "id-type": "DOI" } ], "name": "Tabriz University of Medical Sciences" } ], "indexed": { "date-parts": [ [ 2025, 4, 12 ] ], "date-time": "2025-04-12T22:43:01Z", "timestamp": 1744497781322, "version": "3.37.3" }, "is-referenced-by-count": 5, "issue": "4", "issued": { "date-parts": [ [ 2022, 6, 20 ] ] }, "journal-issue": { "issue": "4", "published-print": { "date-parts": [ [ 2022, 8 ] ] } }, "language": "en", "license": [ { "URL": "https://www.springer.com/tdm", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 6, 20 ] ], "date-time": "2022-06-20T00:00:00Z", "timestamp": 1655683200000 } }, { "URL": "https://www.springer.com/tdm", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 6, 20 ] ], "date-time": "2022-06-20T00:00:00Z", "timestamp": 1655683200000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s10787-022-01001-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s10787-022-01001-2/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s10787-022-01001-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "page": "1277-1282", "prefix": "10.1007", "published": { "date-parts": [ [ 2022, 6, 20 ] ] }, "published-online": { "date-parts": [ [ 2022, 6, 20 ] ] }, "published-print": { "date-parts": [ [ 2022, 8 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.1089/ars.2020.8111", "author": "AS Abouhashem", "doi-asserted-by": "publisher", "first-page": "59", "journal-title": "Antioxid Redox Signal", "key": "1001_CR1", "unstructured": "Abouhashem AS, Singh K, Azzazy HME, Sen CK (2020) Is low alveolar type II cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19? Antioxid Redox Signal 33:59–65. https://doi.org/10.1089/ars.2020.8111", "volume": "33", "year": "2020" }, { "DOI": "10.1073/pnas.93.6.2448", "author": "T Akaike", "doi-asserted-by": "publisher", "first-page": "2448", "journal-title": "Proc Natl Acad Sci USA", "key": "1001_CR2", "unstructured": "Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM et al (1996) Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 93:2448–2453. https://doi.org/10.1073/pnas.93.6.2448", "volume": "93", "year": "1996" }, { "DOI": "10.1093/cid/ciaa1443", "author": "Julio Cesar Garcia de Alencar", "doi-asserted-by": "publisher", "first-page": "e736", "issue": "11", "journal-title": "Clin Infect Dis", "key": "1001_CR20", "unstructured": "de Alencar JCG, de Moreira CL,Müller AD, Chaves CE, Fukuhara MA, da Silva EA, de Miyamoto MFS, Pinto VB, Bueno CG, Neto FL, Gomez LMG, Menezes MCS, Marchini JFM, Marino LO, Brandão Neto RA, Souza HP, (2021) (2020) Double-blind Randomized Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19). Clin Infect Dis 72(11) e736–e741. https://doi.org/10.1093/cid/ciaa1443", "volume": "72", "year": "2021" }, { "DOI": "10.1089/ars.2012.4604", "author": "SI Dikalov", "doi-asserted-by": "publisher", "first-page": "1085", "journal-title": "Antioxid Redox Signal", "key": "1001_CR3", "unstructured": "Dikalov SI, Nazarewicz RR (2013) Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease. Antioxid Redox Signal 19:1085–1094. https://doi.org/10.1089/ars.2012.4604", "volume": "19", "year": "2013" }, { "DOI": "10.1016/j.clim.2020.108544", "author": "H Ibrahim", "doi-asserted-by": "publisher", "first-page": "108544", "journal-title": "Clin Immunol", "key": "1001_CR19", "unstructured": "Ibrahim H, Perl A, Smith D, Lewis T, Kon Z, Goldenberg R, Yarta K, Staniloae C, Williams M (2020) Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine. Clin Immunol 219108544. https://doi.org/10.1016/j.clim.2020.108544", "volume": "219", "year": "2020" }, { "DOI": "10.1186/s40001-021-00490-1", "author": "S JamaliMoghadamSiahkali", "doi-asserted-by": "publisher", "journal-title": "Eur J Med Res", "key": "1001_CR18", "unstructured": "JamaliMoghadamSiahkali S, Zarezade B, Koolaji S, SeyedAlinaghi SA, Zendehdel A, Tabarestani M, Sekhavati Moghadam E, Abbasian L, Manshadi SAD, Salehi M, Hasannezhad M, Ghaderkhani S, Meidani M, Salahshour F, Jafari F, Manafi N, Ghiasvand F (2021) Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. Eur J Med Res 26(1). https://doi.org/10.1186/s40001-021-00490-1", "year": "2021" }, { "DOI": "10.3892/etm.2011.352", "author": "K Kikuchi", "doi-asserted-by": "publisher", "first-page": "3", "journal-title": "Exp Ther Med", "key": "1001_CR4", "unstructured": "Kikuchi K, Takeshige N, Miura N, Morimoto Y, Ito T, Tancharoen S et al (2012) Beyond free radical scavenging: beneficial effects of edaravone (radicut) in various diseases (review). Exp Ther Med 3:3–8. https://doi.org/10.3892/etm.2011.352", "volume": "3", "year": "2012" }, { "DOI": "10.3390/ijms140713909", "author": "K Kikuchi", "doi-asserted-by": "publisher", "first-page": "13909", "journal-title": "Int J Mol Sci", "key": "1001_CR5", "unstructured": "Kikuchi K, Tancharoen S, Takeshige N, Yoshitomi M, Morioka M, Murai Y et al (2013) The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease. Int J Mol Sci 14:13909–13930. https://doi.org/10.3390/ijms140713909", "volume": "14", "year": "2013" }, { "DOI": "10.4172/2153-0645.1000141", "author": "N Komaravelli", "doi-asserted-by": "publisher", "journal-title": "J Pharmacogenomics Pharmacoproteomics", "key": "1001_CR6", "unstructured": "Komaravelli N, Casola A (2014) Respiratory viral infections and subversion of cellular antioxidant defenses. J Pharmacogenomics Pharmacoproteomics. https://doi.org/10.4172/2153-0645.1000141", "year": "2014" }, { "DOI": "10.1016/s0076-6879(02)52039-5", "author": "FR Laurindo", "doi-asserted-by": "publisher", "first-page": "432", "journal-title": "Methods Enzymol", "key": "1001_CR7", "unstructured": "Laurindo FR, de Souza HP, Pedro MA, Janiszewski M (2002) Redox aspects of vascular response to injury. Methods Enzymol 352:432–454. https://doi.org/10.1016/s0076-6879(02)52039-5", "volume": "352", "year": "2002" }, { "DOI": "10.1016/j.toxrep.2020.06.003", "author": "A Nasi", "doi-asserted-by": "publisher", "first-page": "768", "journal-title": "Toxicol Rep", "key": "1001_CR8", "unstructured": "Nasi A, McArdle S, Gaudernack G, Westman G, Melief C, Rockberg J et al (2020) Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention. Toxicol Rep 7:768–771. https://doi.org/10.1016/j.toxrep.2020.06.003", "volume": "7", "year": "2020" }, { "DOI": "10.1093/infdis/jit062", "author": "LA Perrone", "doi-asserted-by": "publisher", "first-page": "1576", "journal-title": "J Infect Dis", "key": "1001_CR9", "unstructured": "Perrone LA, Belser JA, Wadford DA, Katz JM, Tumpey TM (2013) Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice. J Infect Dis 207:1576–1584. https://doi.org/10.1093/infdis/jit062", "volume": "207", "year": "2013" }, { "DOI": "10.3389/fmolb.2021.725528", "author": "SY Rahbar", "doi-asserted-by": "publisher", "journal-title": "Front Mol Biosci", "key": "1001_CR10", "unstructured": "Rahbar SY, Hosseiniyan Khatibi SM, Zununi VS, Ardalan M (2021) Host serine proteases: a potential targeted therapy for COVID-19 and influenza. Front Mol Biosci 8:725528. https://doi.org/10.3389/fmolb.2021.725528", "volume": "8", "year": "2021" }, { "DOI": "10.1016/j.jbior.2020.100741", "author": "G Schönrich", "doi-asserted-by": "publisher", "journal-title": "Adv Biolog Regul", "key": "1001_CR11", "unstructured": "Schönrich G, Raftery MJ, Samstag Y (2020) Devilishly radical NETwork in COVID-19: oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biolog Regul 77:100741. https://doi.org/10.1016/j.jbior.2020.100741", "volume": "77", "year": "2020" }, { "DOI": "10.1080/10715762.2021.1938024", "author": "O Shadyro", "doi-asserted-by": "publisher", "first-page": "745", "journal-title": "Free Radic Res", "key": "1001_CR12", "unstructured": "Shadyro O, Samovich S, Edimecheva I, Novitsky R, Khrutskin V, Ihnatovich L et al (2021) Potential role of free-radical processes in biomolecules damage during COVID-19 and ways of their regulation. Free Radic Res 55:745–756. https://doi.org/10.1080/10715762.2021.1938024", "volume": "55", "year": "2021" }, { "DOI": "10.1007/978-981-32-9366-3_5", "author": "RK Thimmulappa", "doi-asserted-by": "publisher", "first-page": "103", "key": "1001_CR13", "unstructured": "Thimmulappa RK, Chattopadhyay I, Rajasekaran S (2020) Oxidative stress mechanisms in the pathogenesis of environmental lung diseases. Oxidative stress in lung diseases. Springer, Nature Publishing Group, UK, pp 103–137", "volume-title": "Oxidative stress in lung diseases", "year": "2020" }, { "DOI": "10.1042/cs20200363", "author": "RM Touyz", "doi-asserted-by": "publisher", "first-page": "747", "journal-title": "Clin Sci (London, England: 1979)", "key": "1001_CR14", "unstructured": "Touyz RM, Li H, Delles C (2020) ACE2 the Janus-faced protein—from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. Clin Sci (London, England: 1979) 134:747–750. https://doi.org/10.1042/cs20200363", "volume": "134", "year": "2020" }, { "DOI": "10.1111/j.1527-3466.2008.00041.x", "author": "T Watanabe", "doi-asserted-by": "publisher", "first-page": "101", "journal-title": "Cardiovasc Ther", "key": "1001_CR15", "unstructured": "Watanabe T, Tahara M, Todo S (2008) The novel antioxidant edaravone: from bench to bedside. Cardiovasc Ther 26:101–114. https://doi.org/10.1111/j.1527-3466.2008.00041.x", "volume": "26", "year": "2008" }, { "DOI": "10.1016/j.niox.2020.06.002", "author": "J Wu", "doi-asserted-by": "publisher", "first-page": "39", "journal-title": "Nitric Oxide Biol Chem", "key": "1001_CR16", "unstructured": "Wu J (2020) Tackle the free radicals damage in COVID-19. Nitric Oxide Biol Chem 102:39–41. https://doi.org/10.1016/j.niox.2020.06.002", "volume": "102", "year": "2020" }, { "DOI": "10.1186/s13054-020-03015-0", "author": "Z Wu", "doi-asserted-by": "publisher", "first-page": "290", "journal-title": "Crit Care (London, England)", "key": "1001_CR17", "unstructured": "Wu Z, Hu R, Zhang C, Ren W, Yu A, Zhou X (2020) Elevation of plasma angiotensin II level is a potential pathogenesis for the critically Ill COVID-19 patients. Crit Care (London, England) 24:290. https://doi.org/10.1186/s13054-020-03015-0", "volume": "24", "year": "2020" }, { "DOI": "10.1016/j.jpba.2021.113927", "author": "Y Xing", "doi-asserted-by": "publisher", "first-page": "113927", "journal-title": "J Pharm Biomed Anal", "key": "1001_CR21", "unstructured": "Xing Y, Zhao B, Yin L, Guo M, Shi H, Zhu Z, Zhang L, He J,Ling Y,Gao M, Lu H, Mao E, Zhang L (2021) Vitamin C supplementation is necessary for patients with coronavirus disease: An ultra-high-performance liquid chromatography-tandem mass spectrometry finding. J Pharm Biomed Anal 196113927. https://doi.org/10.1016/j.jpba.2021.113927", "volume": "196", "year": "2021" } ], "reference-count": 21, "references-count": 21, "relation": {}, "resource": { "primary": { "URL": "https://link.springer.com/10.1007/s10787-022-01001-2" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial", "type": "journal-article", "update-policy": "https://doi.org/10.1007/springer_crossmark_policy", "volume": "30" }